Key result
Epicardial implantation of a chitosan hydrogel patch enriched with mesenchymal stromal cell secretome improved left ventricle systolic performance and contractility in a rat model of chronic ischemia.
Why the study?
The study assessed the potential benefits of enriching a chitosan hydrogel patch with mesenchymal stromal cell secretome and implanting it epicardially to restore cardiac functional capacity in chronic ischemia.
Does epicardial implantation of a secretome-enriched chitosan hydrogel patch improve cardiac function in a rat model of chronic ischemia?
Does epicardial implantation of a secretome-enriched chitosan hydrogel patch improve cardiac function in a rat model of chronic ischemia?
Epicardial implantation of a chitosan hydrogel patch enriched with mesenchymal stromal cell secretome improved left ventricular systolic performance and contractility in a rat model of myocardial infarction.
Extends preclinical support for secretome-enriched patches in rat ischemia; leaves open translation to human chronic MI.
The aim of this work was to assess the potential benefits of the enrichment of a chitosan hydrogel patch with secretome and its epicardial implantation in a murine model of chronic ischemia, focusing on the potential to restore the functional capacity of the heart. Thus, a hydrogel with a final polymer concentration of 3 % was prepared from chitosan with an acetylation degree of 24 % and then bio-functionalized with a secretome produced by mesenchymal stromal cells. The identification of proteins in the secretomes showed the presence of several proteins known to have beneficial effects on cardiac muscle repair. Then chitosan hydrogels were immersed in secretome. The protein incorporation in the hydrogel and their release over time were studied, demonstrating the ability of the gel to retain and then deliver proteins (around 40 % was released in the first 6 h, and then a plateau was reached). Moreover, mechanical analysis exhibited that the patches remained suturable after enrichment. Finally, bio-functionalized hydrogel patches were sutured onto the surface of the infarcted myocardium in rat. Thirty days after, the presence of enriched hydrogels induced a reversion of cardiac function which seems to come mainly from an improvement of left ventricle systolic performance and contractility. • Development of a chitosan patch with well-chosen physicochemical properties • Patch enrichment with a secretome produced by mesenchymal stromal cells • Identification in secretome of several proteins beneficial to cardiac regeneration • Feasible enrichment of the hydrogel patches with secretome • Beneficial effects of these acellular biofunctionalized patches on cardiac function
No takes yet. Share an insight, caveat, or question.
Domengé et al. (2024) studied Chronic ischemia / infarcted myocardium. Chitosan hydrogel patch enriched with mesenchymal stromal cell secretome was evaluated on Cardiac function (left ventricle systolic performance and contractility). Epicardial implantation of a chitosan hydrogel patch enriched with mesenchymal stromal cell secretome improved left ventricle systolic performance and contractility in a rat model of chronic ischemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: